Infertility due to polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: First intervention group: They will receive tamoxifen tablets (20 mg daily in two doses of 10 mg from the third to the seventh day of the cycle). Intervention 2: Second intervention gr
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Infertile women with polycystic ovary syndrome Women who are candidates for ovarian stimulation and IUI treatment
Exclusion criteria
Exclusion criteria: Unwillingness to participate in the study Drug sensitivity to letrozole, tamoxifen, metformin, gonadotropins presence of any other pathology that has led to infertility in the patient or their partner. Liver or kidney dysfunction Diabetes mellitus type one or two Thyroid dysfunction Congenital adrenal hyperplasia Abnormal hysterosalpingography
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in follicle size. Timepoint: The third, seventh, and twelfth days of the menstrual cycle. Method of measurement: Trans vaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy incidence. Timepoint: At least 14 days after ovulation. Method of measurement: Pregnancy diagnosis will be based on ultrasound and ß-HCG titer levels. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAthar Rasekh Jahromi
Jahrom University of Medical Sciences
Outcome results
None listed